Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 705

1.

[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.

van der Zande JJ, Booij J, Scheltens P, Raijmakers PG, Lemstra AW.

Eur J Nucl Med Mol Imaging. 2016 Jan 30. [Epub ahead of print]

PMID:
26830298
2.

Different patterns of cortical gray matter loss over time in behavioral variant frontotemporal dementia and Alzheimer's disease.

Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Steenwijk MD, Barkhof F, Scheltens P, Vrenken H, van der Flier WM.

Neurobiol Aging. 2016 Feb;38:21-31. doi: 10.1016/j.neurobiolaging.2015.10.020. Epub 2015 Oct 30.

PMID:
26827640
3.

Low Prevalence of Mixed Dementia in a Cohort of 2, 000 Elderly Patients in a Memory Clinic Setting.

Claus JJ, Staekenborg SS, Roorda JJ, Stevens M, Herderschee D, Maarschalkerweerd WV, Schuurmans L, Tielkes CE, Koster P, Bavinck C, Scheltens P.

J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print]

PMID:
26757192
4.

Validation of soluble APP assays as diagnostic CSF biomarkers for neurodegenerative diseases.

van Waalwijk van Doorn LJ, Koel-Simmelink MJ, Haußmann U, Klafki H, Struyfs H, Linning P, Knölker HJ, Twaalfhoven H, Kuiperij HB, Engelborghs S, Scheltens P, Verbeek MM, Vanmechelen E, Wiltfang J, Teunissen CE.

J Neurochem. 2016 Jan 7. doi: 10.1111/jnc.13527. [Epub ahead of print]

PMID:
26748905
5.

Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.

Rosenberger AF, Morrema TH, Gerritsen WH, van Haastert ES, Snkhchyan H, Hilhorst R, Rozemuller AJ, Scheltens P, van der Vies SM, Hoozemans JJ.

J Neuroinflammation. 2016 Jan 6;13(1):4. doi: 10.1186/s12974-015-0470-x.

6.

Disrupted subject-specific gray matter network properties and cognitive dysfunction in type 1 diabetes patients with and without proliferative retinopathy.

van Duinkerken E, Ijzerman RG, Klein M, Moll AC, Snoek FJ, Scheltens P, Pouwels PJ, Barkhof F, Diamant M, Tijms BM.

Hum Brain Mapp. 2015 Dec 23. doi: 10.1002/hbm.23096. [Epub ahead of print]

PMID:
26700243
7.

Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease.

Hafkemeijer A, Möller C, Dopper EG, Jiskoot LC, van den Berg-Huysmans AA, van Swieten JC, van der Flier WM, Vrenken H, Pijnenburg YA, Barkhof F, Scheltens P, van der Grond J, Rombouts SA.

Hum Brain Mapp. 2015 Dec 10. doi: 10.1002/hbm.23081. [Epub ahead of print]

PMID:
26660857
8.

Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis.

Möller C, Pijnenburg YA, van der Flier WM, Versteeg A, Tijms B, de Munck JC, Hafkemeijer A, Rombouts SA, van der Grond J, van Swieten J, Dopper E, Scheltens P, Barkhof F, Vrenken H, Wink AM.

Radiology. 2015 Dec 11:150220. [Epub ahead of print]

PMID:
26653846
9.

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.

Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns NJ, Halliday GM, Mann D, Pickering-Brown S, Powell J, Lunnon K, Lupton MK; International Parkinson's Disease Genomics Consortium (IPDGC), Dickson D, Hardy J, Singleton A, Bras J.

Neurobiol Aging. 2016 Feb;38:214.e7-214.e10. doi: 10.1016/j.neurobiolaging.2015.10.028. Epub 2015 Nov 2.

10.

Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.

Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, Scheltens P, Masters CL, Rowe CC.

J Alzheimers Dis. 2015 Nov 25;49(4):1115-22. doi: 10.3233/JAD-150446.

PMID:
26639956
11.

The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials.

Groot C, Hooghiemstra AM, Raijmakers PG, van Berckel BN, Scheltens P, Scherder EJ, van der Flier WM, Ossenkoppele R.

Ageing Res Rev. 2016 Jan;25:13-23. doi: 10.1016/j.arr.2015.11.005. Epub 2015 Nov 28. Review.

PMID:
26607411
12.

Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment.

Viswanathan A, Greenberg SM, Scheltens P.

Stroke. 2016 Feb;47(2):577-80. doi: 10.1161/STROKEAHA.115.009010. Epub 2015 Nov 24. No abstract available.

PMID:
26604252
13.

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study.

Möller C, Hafkemeijer A, Pijnenburg YA, Rombouts SA, van der Grond J, Dopper E, van Swieten J, Versteeg A, Pouwels PJ, Barkhof F, Scheltens P, Vrenken H, van der Flier WM.

Neuroimage Clin. 2015 Sep 9;9:418-29. doi: 10.1016/j.nicl.2015.08.022. eCollection 2015.

14.

Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers.

Rhodius-Meester HF, Koikkalainen J, Mattila J, Teunissen CE, Barkhof F, Lemstra AW, Scheltens P, Lötjönen J, van der Flier WM.

J Alzheimers Dis. 2015 Nov 13;50(1):261-70. doi: 10.3233/JAD-150548.

PMID:
26577521
15.

Gray matter network disruptions and amyloid beta in cognitively normal adults.

Tijms BM, Kate MT, Wink AM, Visser PJ, Ecay M, Clerigue M, Estanga A, Garcia Sebastian M, Izagirre A, Villanua J, Martinez Lage P, van der Flier WM, Scheltens P, Sanz Arigita E, Barkhof F.

Neurobiol Aging. 2016 Jan;37:154-60. doi: 10.1016/j.neurobiolaging.2015.10.015. Epub 2015 Oct 22.

PMID:
26559882
16.

Hypertensive Disorders of Pregnancy Appear Not to Be Associated with Alzheimer's Disease Later in Life.

Abheiden CN, van Doornik R, Aukes AM, van der Flier WM, Scheltens P, de Groot CJ.

Dement Geriatr Cogn Dis Extra. 2015 Sep 30;5(3):375-85. doi: 10.1159/000439043. eCollection 2015 Sep-Dec.

17.

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.

Reijs BL, Teunissen CE, Goncharenko N, Betsou F, Blennow K, Baldeiras I, Brosseron F, Cavedo E, Fladby T, Froelich L, Gabryelewicz T, Gurvit H, Kapaki E, Koson P, Kulic L, Lehmann S, Lewczuk P, Lleó A, Maetzler W, de Mendonça A, Miller AM, Molinuevo JL, Mollenhauer B, Parnetti L, Rot U, Schneider A, Simonsen AH, Tagliavini F, Tsolaki M, Verbeek MM, Verhey FR, Zboch M, Winblad B, Scheltens P, Zetterberg H, Visser PJ.

Front Neurol. 2015 Oct 15;6:216. doi: 10.3389/fneur.2015.00216. eCollection 2015.

18.

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Rosenberger AF, Hilhorst R, Coart E, García Barrado L, Naji F, Rozemuller AJ, van der Flier WM, Scheltens P, Hoozemans JJ, van der Vies SM.

J Alzheimers Dis. 2015 Oct 27;49(4):927-43. doi: 10.3233/JAD-150429.

PMID:
26519433
19.

Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges.

Dubois B, Padovani A, Scheltens P, Rossi A, Dell'Agnello G.

J Alzheimers Dis. 2015 Oct 17;49(3):617-31. doi: 10.3233/JAD-150692.

PMID:
26484931
20.

Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort.

Krudop WA, Dols A, Kerssens CJ, Prins ND, Möller C, Schouws S, Barkhof F, van Berckel BN, Teunissen CE, van der Flier WM, Scheltens P, Sikkes SA, Stek ML, Pijnenburg YA.

Dement Geriatr Cogn Disord. 2015 Oct 17;41(1-2):16-26. [Epub ahead of print]

PMID:
26473985
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk